Patents by Inventor Didier BORDERIE

Didier BORDERIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A SERS METHOD FOR ANALYZING A VISCOUS BIOFLUID
    Publication number: 20220349902
    Abstract: The invention relates to a SERS method for analyzing a biological sample, the method comprising the following step of: a. obtaining a biological sample which is viscous biofluid, b. depositing at least one droplet of the biological sample onto a microscope slide, and drying the droplet, c. depositing a drop of an aqueous dispersion of metallic nanoparticles above the droplet dried in step b), to have a dense distribution of nanoparticles on the surface of the dried droplet and to obtain a SERS-activated biological sample, d. drying the SERS-activated biological sample, e. irradiating the SERS-activated biological sample using a light source to obtain a SERS spectrum, and f. collecting the SERS spectrum.
    Type: Application
    Filed: September 23, 2020
    Publication date: November 3, 2022
    Inventors: François RANNOU, Amanda ROBINSON, Didier BORDERIE, François ETIENNE, Cyril GOBINET, Christelle NGUYEN, Claire MANGENEY, Olivier PIOT
  • COLL2-1 PEPTIDE AND ITS NITRATED FORM AS THERAPEUTIC TARGETS FOR OSTEOARTHRITIS TREATMENT
    Publication number: 20200347121
    Abstract: The present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of osteoarthritis. Further, the present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of rheumatic and musculoskeletal diseases (RMDs).
    Type: Application
    Filed: May 4, 2020
    Publication date: November 5, 2020
    Applicants: Université de Liège, Université Paris Descartes, Assistance Publique Hopitaux de Paris, Institut National de la Santé et de la Recherche Médicale
    Inventors: Yves HENROTIN, Cécile LAMBERT, Didier BORDERIE, François RANNOU
  • COLL2-1 PEPTIDE AND ITS NITRATED FORM AS THERAPEUTIC TARGETS FOR OSTEOARTHRITIS TREATMENT
    Publication number: 20170320939
    Abstract: The present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of osteoarthritis. Further, the present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of rheumatic and musculoskeletal diseases (RMDs).
    Type: Application
    Filed: June 16, 2017
    Publication date: November 9, 2017
    Applicants: Université de Liège, Université Paris Descartes, Assistance Publique Hopitaux de Paris, Institut National de la Santé et de la Recherche Médicale
    Inventors: Yves HENROTIN, Cécile LAMBERT, Didier BORDERIE, François RANNOU